Arix Bioscience PLC
LSE:ARIX

Watchlist Manager
Arix Bioscience PLC Logo
Arix Bioscience PLC
LSE:ARIX
Watchlist
Price: 142 GBX
Market Cap: £183.7m

Operating Margin

-7 826%
Current
Declining
by 1 550%
vs 3-y average of -6 275.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-7 826%
=
Operating Income
£-6m
/
Revenue
£77k

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-7 826%
=
Operating Income
GBX-6m
/
Revenue
£77k

Peer Comparison

Country Company Market Cap Operating
Margin
UK
Arix Bioscience PLC
LSE:ARIX
183.8m GBP
Loading...
US
Blackstone Inc
NYSE:BX
181.4B USD
Loading...
US
BlackRock Inc
NYSE:BLK
170.9B USD
Loading...
CA
Brookfield Corp
NYSE:BN
106.4B USD
Loading...
US
KKR & Co Inc
NYSE:KKR
103.5B USD
Loading...
CA
BROOKFIELD ASSET MANAGEMENT LTD
TSX:BAM
112.8B CAD
Loading...
US
BROOKFIELD ASSET MANAGEMENT LTD
F:RW5
68.9B EUR
Loading...
CA
Brookfield Asset Management Inc
NYSE:BAM
82.9B USD
Loading...
US
Bank of New York Mellon Corp
NYSE:BK
81.6B USD
Loading...
SE
EQT AB
STO:EQT
415.8B SEK
Loading...
US
Ameriprise Financial Inc
NYSE:AMP
46.4B USD
Loading...

Market Distribution

Lower than 99% of companies in United Kingdom
Percentile
1st
Based on 3 579 companies
1st percentile
-7 826%
Low
-195 650% — 0%
Typical Range
0% — 0.2%
High
0.2% — 4 630.7%
Distribution Statistics
United Kingdom
Min -195 650%
30th Percentile 0%
Median 0.1%
70th Percentile 0.2%
Max 4 630.7%

Arix Bioscience PLC
Glance View

Market Cap
183.7m GBX
Industry
Financial Services

Arix Bioscience Plc is a global venture capital company. The firm is a holding company that is focused on generating value from the development and commercialization of technologies and discoveries. The firm's principal activity is to source, finance and develop healthcare and life science businesses across the world. The firm focuses on acquiring interests in, and provide operational oversight to, healthcare and life science businesses with which it partners in the healthcare and life science sector. The Company’s portfolio includes Harpoon Therapeutics, Inc. (HARP), Artios Pharma Ltd (Artios), Aura Biosciences Inc (Aura), LogicBio Therapeutics, Inc. (LOGC). The firm's subsidiaries include Depixus SAS (EUR), Quench Bio, Inc., Stipe Therapeutics Aps and Twelve Bio Aps.

ARIX Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-7 826%
=
Operating Income
£-6m
/
Revenue
£77k
What is Arix Bioscience PLC's current Operating Margin?

The current Operating Margin for Arix Bioscience PLC is -7 826%, which is below its 3-year median of -6 275.9%.

How has Operating Margin changed over time?

Over the last 2 years, Arix Bioscience PLC’s Operating Margin has decreased from -1 273.5% to -7 826%. During this period, it reached a low of -7 826% on Jul 30, 2023 and a high of -1 273.5% on May 30, 2021.

Back to Top